Personalized Cancer Detection. Built around the individual.
Explore the SimpleScreen portfolio.
SimpleScreen brings blood-based screening options together in one portfolio. Select a test to learn more.
What it is:
A laboratory-developed test for lung cancer screening
Who it's for:
Adults ages 50-80 with a 20 pack-year history of smoking who have not completed lung cancer screening with low-dose CT.
If the result is positive:
Follow up with low-dose CT.
If the result is negative:
Continue with screening plans based on clinical judgment. When appropriate, repeat SimpleScreen Lung every year if the result is negative.
What it is:
An FDA-approved blood-based screening test for colorectal cancer
Who it's for:
Adults ages 45 and older at average risk for colorectal cancer who have not completed colonoscopy or stool-based colorectal cancer screening
If the result is positive:
Follow up with a colonoscopy.
If the result is negative:
Continue with screening plans based on clinical judgment. If SimpleScreen CRC is elected again, the test is repeated every three years when the result is negative.
Additional indications
The SimpleScreen portfolio will grow as Freenome launches additional cancer screening tests.
The SimpleScreen Lung laboratory developed test has not been reviewed or cleared/approved by U.S. Food and Drug Administration (FDA)
Precaution: Based on data from clinical studies, SimpleScreen CRC has limited detection (57%) of Stage I colorectal cancer (64% when U.S. 2020 Census age-sex adjusted) and does not detect 87% of advanced precancerous lesions (86% when U.S. 2020 Census age-sex adjusted). One out of 10 patients with a negative SimpleScreen CRC result may have a precancer that would have been detected by a screening colonoscopy.
Intended Use: The SimpleScreen™ CRC test is a qualitative, in vitro diagnostic test intended to detect molecular signals associated with colorectal cancer. SimpleScreen CRC utilizes circulating cell-free DNA from plasma of peripheral whole blood collected in the SimpleScreen CRC blood collection kit.
SimpleScreen CRC is indicated for colorectal cancer screening in adults aged 45 years and older who are at average risk for the disease. Patients with a positive result should be followed by colonoscopy. SimpleScreen CRC is not a replacement for diagnostic colonoscopy or for surveillance colonoscopy in high-risk individuals.
Additional information about SimpleScreen CRC: